Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The autophagy pathway is a highly conserved cellular process responsible for degrading and recycling unnecessary or dysfunctional cellular components through lysosome-dependent mechanisms. It plays a crucial role in maintaining cellular homeostasis, especially under stress conditions. The pathway involves several key stages: initiation, nucleation, expansion & cargo sequestration, maturation & fusion, and degradation & recycling. Dysregulation of autophagy is implicated in various diseases, including cancer, neurodegenerative diseases, and infectious diseases, making it a potential therapeutic target.
mTOR inhibitors suppress mTOR activity, promoting autophagy. Autophagy inhibitors block lysosomal degradation, impairing autophagic flux.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autophagy Pathway (N/A).